✦ LIBER ✦

Single i.v. infusion of clodronate 1500 mg is effective in the treatment of hypercalcemia of malignancy

✍ Scribed by Atula, S.; Tahtela, R.; Nevalainen, J.; Pylkkanen, L.

Book ID: 122073748
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 172 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(01)81808-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone and renal components in hypercalcem

Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate

✍ Bonjour, J.-P.; Philippe, J.; Guelpa, G.; Bisetti, A.; Rizzoli, R.; Jung, A.; Ro 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 972 KB

Single-dose intravenous therapy with pam

Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosages

✍ Samuel R. Nussbaum; Jerry Younger; Christine J. Vandepol; Robert F. Gagel; Mary 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 973 KB

Daunomycin administered by continuous in

Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia

✍ Jerry P. Lewis; Frederick J. Meyers; Leora Tanaka 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Losartan 100 mg/hydrochlorothiazide 25 m

Losartan 100 mg/hydrochlorothiazide 25 mg is effective and well tolerated in the treatment of moderate-to-severe essential hypertension

✍ Alan H. Gradman; William E. Brady; Lisa P. Gazdick; Kevin J. Gergich; Paulette A 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 35 KB

Lanzoprazole 30 mg is as effective as om

Lanzoprazole 30 mg is as effective as omeprazole 20 mg in the treatment of moderate and severe erosive reflux esophagitis (ERE)

✍ Jorge Olmos; Roberto Higa; Jorge Davolos; Alejandro Gards 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi